slide slide slide slide slide slide slide slide slide

IQ Symposium 2022

Emerging Trends in Pharmaceutical Innovation: Novel Modalities and Development Strategies -- 13 Oct 2022 - Register Now!

Read More >

IQ CMC Summit 2022

Register Now! Building upon the Conventional & Collaborating on Novel & Emerging Areas in Bio/Pharma/Medical Device Industries - 12 Oct 2022

Read More >

IQ Leadership Group Meetings

IQ Members Register Now!

Read More >

IQ Annual Report 2021

The IQ Consortium proudly shares its 2021 accomplishments in its newly released annual report.

Read More >

IQ's Diversity and Inclusion Statement

Read the IQ Consortium's commitment to Diversity and Inclusion.

Read More >

IQ's First Decade

Read testimonials from current and past IQ members on the new series, Reflections from IQ Leaders.

Read More >

IQ Microphyiological Systems Affiliate

The IQ MPS Affiliate issues RFI on "Gastrointestinal Microphysiological System Testing for Specific Contexts of Use in Drug Development."

Read More >

IQ DILI Affiliate

Find out about the IQ DILI affiliate's latest publication in AP&T for adults with cholestatic liver disease.

Read More >

Join the IQ Consortium

Learn more about how you and your company can become involved.

Read More >

What is IQ?

The IQ Consortium is a not-for-profit organization of pharmaceutical and biotechnology companies with the mission of advancing science and technology to augment the capability of member companies to develop transformational solutions that benefit patients, regulators and the broader R&D community.

News

news image

IQ Symposium Featured Speaker, Pat Furlong

September 2022

IQ Consortium is honored to announce that Pat Furlong, CEO of Parent Project Muscular Dystrophy, will present the patient perspective at the 13 October IQ Symposium.

news image

IQ CMC Summit Featured Speaker, Venkat Koganti

September 2022

The IQ Consortium is pleased to include a presentation from Venkat Koganti, Bristol Myers Squibb, on long-acting injectables versatility in delivering novel therapeutics.

See other news

Events

See other upcoming events